|
WO2008118862A1
|
|
Carotenoid analogs and derivatives for the prevention of platelet aggregation
|
|
WO2008106606A2
|
|
Carotenoid analogs and derivatives in the treatment of prostate cancer
|
|
WO2007090095A2
|
|
Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics
|
|
EP1957057A1
|
|
Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status
|
|
US2006183947A1
|
|
Methods for the synthesis of astaxanthin
|
|
US2005261254A1
|
|
Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
|
|
US7521584B2
|
|
Carotenoid analogs or derivatives for the inhibition and amelioration of disease
|
|
US7320997B2
|
|
Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
|
|
US7345091B2
|
|
Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
|
|
US7763649B2
|
|
Carotenoid analogs or derivatives for controlling connexin 43 expression
|
|
US7723327B2
|
|
Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
|
|
US7375133B2
|
|
Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
|
